(Q38541697)

2 July 2019

3 references

17 September 2019

19 September 2019

14 October 2020

A Highlight of Recent Advances in Aptamer Technology and Its Application (English)

1 reference

2 July 2019

biomedical investigative technique

1 reference

17 September 2019

1 reference

19 September 2019

1 reference

14 October 2020

Hongguang Sun

1

1 reference

2 July 2019

Youli Zu

series ordinal

2

1 reference

2 July 2019

language of work or name

English

0 references

publication date

30 June 2015

4 references

2 July 2019

17 September 2019

19 September 2019

14 October 2020

4 references

2 July 2019

17 September 2019

19 September 2019

14 October 2020

20

1 reference

2 July 2019

issue

7

1 reference

2 July 2019

page(s)

11959-11980

1 reference

2 July 2019

Creative Commons Attribution

copyright license

3 references

17 September 2019

19 September 2019

14 October 2020

0 references

In vitro selection of RNA molecules that bind specific ligands

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Nanoscaled aptasensors for multi-analyte sensing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Adaptive recognition by nucleic acid aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Pegaptanib for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Discovery and development of anticancer aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

DNA ligands that bind tightly and selectively to cellobiose

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Capture-SELEX: Selection of DNA Aptamers for Aminoglycoside Antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamers evolved from live cells as effective molecular probes for cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Current approaches in SELEX: An update to aptamer selection technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Microfluidic approaches to rapid and efficient aptamer selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer-based multiplexed proteomic technology for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Selection of LNA-containing DNA aptamers against recombinant human CD73.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Development of DNA aptamers using Cell-SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Targeting cancer cells with nucleic acid aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Oligonucleotide aptamers: new tools for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

In vitro selection using modified or unnatural nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Direct in vitro selection of a 2'-O-methyl aptamer to VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Prion-protein-specific aptamer reduces PrPSc formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

SELEX with modified nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Properties of an LNA-modified ricin RNA aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Synthetic genetic polymers capable of heredity and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Spiegelmers: Biostable Aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Novel combinatorial selection of phosphorothioate oligonucleotide aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Generation of high-affinity DNA aptamers using an expanded genetic alphabet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamers as therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Population pharmacokinetics of pegaptanib in patients with neovascular, age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Highly efficient inhibition of human immunodeficiency virus type 1 reverse transcriptase by aptamers functionalized gold nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Design, synthesis, and amplification of DNA pools for in vitro selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Methods for selection of aptamers to protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A review of therapeutic aptamer conjugates with emphasis on new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Identification of a T7 RNA polymerase variant that permits the enzymatic synthesis of fully 2'-O-methyl-modified RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Nucleic acid aptamers: research tools in disease diagnostics and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Selective aptamer-based control of intraneuronal signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Development of a fraction collection approach in capillary electrophoresis SELEX for aptamer selection

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

By-product formation in repetitive PCR amplification of DNA libraries during SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Emulsion PCR significantly improves nonequilibrium capillary electrophoresis of equilibrium mixtures-based aptamer selection: allowing for efficient and rapid selection of aptamer to unmodified ABH2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Just in time-selection: A rapid semiautomated SELEX of DNA aptamers using magnetic separation and BEAMing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Identification and Characterization of an eIF4e DNA Aptamer That Inhibits Proliferation With High Throughput Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Array-based discovery of aptamer pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Selection of aptamers targeting the sialic acid receptor of hemagglutinin by epitope-specific SELEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Quantitative selection and parallel characterization of aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A novel immobilization strategy for electrochemical detection of cancer biomarkers: DNA-directed immobilization of aptamer sensors for sensitive detection of prostate specific antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Ultrasensitive colorimetric detection of 17β-estradiol: the effect of shortening DNA aptamer sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer-conjugated graphene oxide membranes for highly efficient capture and accurate identification of multiple types of circulating tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer-conjugated polymeric nanoparticles for the detection of cancer cells through "turn-on" retro-self-quenched fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer-functionalized barcode particles for the capture and detection of multiple types of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Dual aptamer-functionalized silica nanoparticles for the highly sensitive detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Using DNA aptamer probe for immunostaining of cancer frozen tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Multifunctional aptamer-silver conjugates as theragnostic agents for specific cancer cell therapy and fluorescence-enhanced cell imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

PET imaging of tenascin-C with a radiolabeled single-stranded DNA aptamer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Specific and sensitive tumor imaging using biostable oligonucleotide aptamer probes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Simultaneous imaging of two different cancer biomarkers using aptamer-conjugated quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Selective uptake and imaging of aptamer- and antibody-conjugated hollow nanospheres targeted to epidermal growth factor receptors overexpressed in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A cell-targeted, size-photocontrollable, nuclear-uptake nanodrug delivery system for drug-resistant cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Target-responsive DNA hydrogel mediated "stop-flow" microfluidic paper-based analytic device for rapid, portable and visual detection of multiple targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A sensitive lateral flow biosensor for Escherichia coli O157:H7 detection based on aptamer mediated strand displacement amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Colorimetric photonic hydrogel aptasensor for the screening of heavy metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamers: active targeting ligands for cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer-mediated cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamers and their applications in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Replacing antibodies with aptamers in lateral flow immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Recent trends in SELEX technique and its application to food safety monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer based electrochemical sensors for emerging environmental pollutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Cell-specific aptamer probes for membrane protein elucidation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Selection of aptamers for molecular recognition and characterization of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Characterization and target identification of a DNA aptamer that labels pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Ets1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

A cancer cell-activatable aptamer-reporter system for one-step assay of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Use of a conformational switching aptamer for rapid and specific ex vivo identification of central nervous system lymphoma in a xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Regulation of singlet oxygen generation using single-walled carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

RNA aptamers as reversible antagonists of coagulation factor IXa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Methods To Identify Aptamers against Cell Surface Biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES200711959

Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.

21 January 2018

1 reference

12 December 2020

An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform

1 reference

12 December 2020

Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration

1 reference

12 December 2020

Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9

1 reference

12 December 2020

Design, synthesis, and amplification of DNA pools for in vitro selection

1 reference

12 December 2020

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.

1 reference

12 December 2020

AptaCluster - A Method to Cluster HT-SELEX Aptamer Pools and Lessons from its Application

1 reference

12 December 2020

Indirect purification method provides high yield and quality ssDNA sublibrary for potential aptamer selection

1 reference

12 December 2020

Highly amplified detection of visceral adipose tissue-derived serpin (vaspin) using a cognate aptamer duo

1 reference

12 December 2020

Electrochemiluminescence biosensor for ultrasensitive determination of ochratoxin A in corn samples based on aptamer and hyperbranched rolling circle amplification

1 reference

12 December 2020

A new application of aptamer: One-step purification and immobilization of enzyme from cell lysates for biocatalysis

1 reference

12 December 2020

A signal-on fluorescent aptasensor based on single-stranded DNA-sensitized luminescence of terbium (III) for label-free detection of breast cancer cells

1 reference

12 December 2020

Selection of an RNA domain that binds Zn2+

1 reference

12 December 2020

Aptamers as therapeutic and diagnostic reagents: problems and prospects

1 reference

12 December 2020

10.3390/MOLECULES200711959

Identifiers

DOI

1 reference

2 July 2019

release_37e4zflbsbc2des5ajt7vpcluu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/37e4zflbsbc2des5ajt7vpcluu

24 November 2022

mapped directly with Wikidata item

PMC publication ID

6331864

1 reference

2 July 2019

PubMed publication ID

26133761

1 reference

2 July 2019